CUE

Cue Biopharma (CUE)

Cue Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CUE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/11	05 : 00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CUE	Cue Biopharma Inc
2024/09/09	21 : 00	GlobeNewswire Inc.	Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer	NASDAQ:CUE	Cue Biopharma Inc
2024/09/06	05 : 00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/09/06	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/09/04	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/09/03	21 : 00	GlobeNewswire Inc.	Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference	NASDAQ:CUE	Cue Biopharma Inc
2024/08/29	05 : 00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:CUE	Cue Biopharma Inc
2024/08/20	05 : 05	GlobeNewswire Inc.	Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CUE	Cue Biopharma Inc
2024/08/17	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/08/15	05 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CUE	Cue Biopharma Inc
2024/08/13	21 : 00	GlobeNewswire Inc.	Cue Biopharma to Host Business Update Call and Webcast	NASDAQ:CUE	Cue Biopharma Inc
2024/07/26	05 : 05	GlobeNewswire Inc.	Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements	NASDAQ:CUE	Cue Biopharma Inc
2024/07/26	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/06/04	21 : 00	GlobeNewswire Inc.	Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting	NASDAQ:CUE	Cue Biopharma Inc
2024/06/03	21 : 00	GlobeNewswire Inc.	Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024	NASDAQ:CUE	Cue Biopharma Inc
2024/05/25	05 : 00	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CUE	Cue Biopharma Inc
2024/05/10	05 : 05	GlobeNewswire Inc.	Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CUE	Cue Biopharma Inc
2024/05/10	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/05/10	05 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CUE	Cue Biopharma Inc
2024/05/08	21 : 00	GlobeNewswire Inc.	Cue Biopharma to Present at the 20th Annual PEGS Boston Summit	NASDAQ:CUE	Cue Biopharma Inc
2024/05/07	21 : 00	GlobeNewswire Inc.	Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference	NASDAQ:CUE	Cue Biopharma Inc
2024/04/24	23 : 01	GlobeNewswire Inc.	Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:CUE	Cue Biopharma Inc
2024/04/09	05 : 05	GlobeNewswire Inc.	Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights	NASDAQ:CUE	Cue Biopharma Inc
2024/04/02	21 : 00	GlobeNewswire Inc.	Cue Biopharma to Host Business Update Call and Webcast	NASDAQ:CUE	Cue Biopharma Inc
2024/03/09	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc